Literature DB >> 8830809

Conformal treatment planning for interstitial brachytherapy.

G Kovács1, D Hebbinghaus, P Dennert, P Kohr, R Wilhelm, B Kimmig.   

Abstract

PURPOSE: Quality of a brachytherapy application depends on the choice of the target volume, on the dose distribution homogeneity and radiation injury on critical tissue, which should be postulated by advanced brachytherapy treatment planning systems.
MATERIAL AND METHODS: Basic imaging method for conformal treatment planning is the cross-sectional imaging. The clinical applicability of a new type 3D planning system using CT and/or MRT-simulation or US-simulation for planning purposes was studied. The planning system developed at Kiel University differs from usual brachytherapy planning systems because of the obligatory use of cross-sectional imaging as basic imaging method for reconstruction of structures of interest. Dose distribution and normal anatomy can be visualized on each CT/MRT/US slice as well as coronal, sagittal, axial and free chosen reconstruction (3D), as well as dose-volume histogram curves and special colour-coded visualization of dose homogeneity in the target can be analyzed.
RESULTS: Because of the experience in the clinical routine, as well as on the base of 30 simultaneous planning procedures on both 2D (semi-3D) and 3D planning systems we observed similar time consumption. Advantages of 3D planning were the better interpretation of target delineation, delineation of critical structures as well as dose distribution, causing more accurate volume optimisation of dose distribution.
CONCLUSION: Conformal brachytherapy treatment planning for interstitial brachytherapy means significant advantages for the clinical routine compared to 2D or semi-3D methods.

Entities:  

Mesh:

Year:  1996        PMID: 8830809

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  [3D navigation for interstitial stereotaxic brachytherapy].

Authors:  T Auer; E Hensler; P Eichberger; A Bluhm; A Gunkel; W Freysinger; R Bale; O Gaber; W F Thumfart; P Lukas
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

2.  [First experiences with computer-assisted frameless stereotactic interstitial brachytherapy (CASIB)].

Authors:  R J Bale; W Freysinger; A Martin; M Vogele; T Auer; P Eichberger; E Hensler; A Sztankay; T Auberger; A R Gunkel; W F Thumfart; P Lukas
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 3.621

3.  Interstitial brachytherapy in soft tissue sarcomas. The Tata Memorial Hospital experience.

Authors:  A J Chaudhary; S Laskar; R Badhwar
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

Review 4.  Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.

Authors:  György Kovács
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

5.  Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer.

Authors:  Georgina Fröhlich; Gyula Geszti; Júlia Vízkeleti; Péter Ágoston; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2019-09-03       Impact factor: 3.621

Review 6.  Techniques to modulate radiotherapy toxicity and outcome in soft tissue sarcoma.

Authors:  Brian O'Sullivan; Iain Ward; Tara Haycocks; Michael Sharpe
Journal:  Curr Treat Options Oncol       Date:  2003-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.